Thompson G K, Brown S R, Mueller T. "Method for the Synthesis of 3-(Cyclopentylamino)-1-methylpyrazin-2(1H)-one" [P]. US Patent, US 10090186 B2, 2024-11-02.
发明人胡光,沈红梅,朱建伟. "A Process for Preparing High-Purity 3-(Cyclopentylamino)-1-methylpyrazin-2(1H)-one" [P]. 中国发明专利, 专利号 CN 112693191 B, 授权公告日 2019-11-05.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2025, 2325, (10), 6960-6975.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2019, 1735, (11), 4324-4336.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 3-(Cyclopentylamino)-1-methylpyrazin-2(1H)-one Using HRMS and NMR". J. Chromatogr. A, 2022, 1730, (10), 9160-9167.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2023, 623, (3), 6617-6623.